Tower Research Capital LLC (Trc) Haemonetics Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Haemonetics Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,181 shares of HAE stock, worth $307,261. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,181
Previous 8,704
51.96%
Holding current value
$307,261
Previous $649,000
68.72%
% of portfolio
0.01%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding HAE
# of Institutions
339Shares Held
50.2MCall Options Held
666KPut Options Held
395K-
Black Rock Inc. New York, NY5.96MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$355 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY3.67MShares$270 Million0.14% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.13MShares$156 Million0.07% of portfolio
-
State Street Corp Boston, MA1.8MShares$132 Million0.0% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.77B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...